Safety and imunogenecity of Meningococcal B Vaccine (4CMenB, Bexsero) in Healthy adults
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Meningococcal vaccine group B OMV Novartis (Primary)
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
- 29 Sep 2016 New trial record